Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Bayer introduces statin in Germany

Nov. 25, 1997

Novel beta-agonists for obesity and diabetes described by SmithKline Beecham

Nov. 25, 1997

Dainippon's aldose reductase inhibitor in preclinical testing

Nov. 25, 1997

Novartis launches once-monthly formulation of Sandostatin

Nov. 24, 1997

Role of substance P in PTH secretion described

Nov. 24, 1997

GH secretagogues under development at Merck & Co.

Nov. 24, 1997

Clinical trial demonstrates efficacy of NPS-R-568 in hyperparathyroidism

Nov. 24, 1997

Olpadronate associated with improvement in osteogenesis imperfecta

Nov. 24, 1997

Amylin, SIDDCO join forces for metabolic drug discovery

Nov. 21, 1997

Novel agent for insulin resistance, S-15261, evaluated in rat model

Nov. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...